US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 44.220
  • +0.750+1.73%
Close Dec 20 16:00 ET
  • 44.220
  • 0.0000.00%
Post 20:01 ET
4.08BMarket Cap-6.96P/E (TTM)

About Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical, Inc. engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010, and is headquartered in Novato, CA.

Company Profile

SymbolRARE
Company NameUltragenyx Pharmaceutical
Listing DateJan 31, 2014
Issue Price21.00
Founded2010
CEODr. Emil D. Kakkis, M.D.,PhD
MarketNASDAQ
Employees1276
Fiscal Year Ends12-31
Address60 Leveroni Court
CityNovato
ProvinceCalifornia
CountryUnited States of America
Zip Code94949
Phone1-415-483-8800

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Emil D. Kakkis, M.D.,PhD
  • Director, President, Chief Executive Officer
  • 13.08M
  • Dennis Karl Huang
  • Chief Technical Operations Officer and Executive Vice President, Gene Therapy Operations
  • --
  • Karah Parschauer
  • Chief Legal Officer and Executive Vice President, Corporate Affairs
  • 4.04M
  • John Richard Pinion, II
  • Chief Quality Officer and Executive Vice President, Translational Sciences
  • 4.05M
  • Thomas R. Kassberg
  • Chief Business Officer and Executive Vice President
  • --
  • Erik Harris
  • Chief Commercial Officer and Executive Vice President
  • 4.07M
  • Howard Horn
  • Chief Financial Officer and Executive Vice President, Corporate Strategy
  • 5.94M
  • Dr. Eric Crombez, M.D.
  • Executive Vice President and Chief Medical Officer
  • --
  • Theodore A. Huizenga
  • Senior Vice President, Corporate Controller and Chief Accounting Officer
  • --
  • Daniel G. Welch
  • Chairman of the Board
  • 499.89K
  • Dr. Corazon Dating Sanders, PhD
  • Independent Director
  • 469.39K
  • Matthew K. Fust
  • Independent Director
  • 479.89K
  • Dr. Amrit Ray, M.D.
  • Independent Director
  • 460.39K
  • Dr. Deborah L. Dunsire,M.D.
  • Independent Director
  • 459.89K
  • Michael A. Narachi
  • Independent Director
  • 482.39K
  • Dr. Shehnaaz Suliman, M.D.
  • Independent Director
  • 466.89K
Heat List
US
Overall
Symbol
Price
% Chg

No Data